LANCRIX

Shopping Cart(0) | Register

Email Password 

Remember me on this computer  |  Forgot password?

Dacomitinib, ≥98%

Catalog No. 717371

General Information
SynonymsPF-00299804
CAS No.1110813-31-4
M.F.

C24H25ClFN5O2

M.W.469.94
Technical Data
Assay≥98%
SolubilityDMSO >10 mg/ml (25℃)
Storage-20℃
DescriptionDacomitinib is an orally bioavailable and highly selective inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity.
Reference

Bello CL, et al. Cancer Chemother Pharmacol. 2013 Aug;72(2):379-85
Ramalingam SS, et al. J Clin Oncol. 2012 Sep 20;30(27):3337-44
Kalous O, et al. Mol Cancer Ther. 2012 Sep;11(9):1978-87
Ather F, et al. PLoS One. 2013;8(2):e56112

Size Price Quantity Favorites
10 mg USD230
50 mg USD690

Please inquire for non-standard packs and bulk quantities.

Availability: Ships in 1-3 days

For research use only. Not for human use.

> Certificate of Analysis

> MSDS